One of the most prominent is the increase in glutamine consumption, which is reflected by the upregulation of the key glutamine transporters (SLC1A5 and the SLC7A5–SLC3A2 dimeric complex) at the surface of the tumour cells. Here, SLC1A5 is linked to neoplasm.